Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Last Close
Mar 12  •  04:00PM ET
33.04
Dollar change
-0.32
Percentage change
-0.96
%
Index- P/E29.45 EPS (ttm)1.12 Insider Own0.10% Shs Outstand436.75M Perf Week-5.19%
Market Cap14.03B Forward P/E13.25 EPS next Y2.49 Insider Trans0.00% Shs Float424.05M Perf Month-6.61%
Enterprise Value16.80B PEG1.28 EPS next Q- Inst Own8.34% Short Float0.74% Perf Quarter0.12%
Income493.76M P/S2.35 EPS this Y9.96% Inst Trans-5.77% Short Ratio3.55 Perf Half Y-12.96%
Sales5.97B P/B2.61 EPS next Y11.14% ROA4.65% Short Interest3.12M Perf YTD0.70%
Book/sh12.66 P/C20.77 EPS next 5Y10.32% ROE9.20% 52W High38.79 -14.82% Perf Year14.56%
Cash/sh1.59 P/FCF17.54 EPS past 3/5Y41.41% 6.97% ROIC5.59% 52W Low23.91 38.18% Perf 3Y15.16%
Dividend Est.0.82 (2.47%) EV/EBITDA10.76 Sales past 3/5Y5.84% 6.10% Gross Margin70.04% Volatility2.53% 1.86% Perf 5Y-16.01%
Dividend TTM0.76 (2.31%) EV/Sales2.81 EPS Y/Y TTM61.52% Oper. Margin15.29% ATR (14)0.87 Perf 10Y1.26%
Dividend Ex-DateMar 27, 2026 Quick Ratio1.40 Sales Y/Y TTM5.78% Profit Margin8.27% RSI (14)36.39 Recom2.31
Dividend Gr. 3/5Y0.91% 0.54% Current Ratio3.00 EPS Q/Q36.89% SMA20-6.81% Beta0.68 Target Price37.79
Payout52.03% Debt/Eq0.62 Sales Q/Q5.69% SMA50-3.99% Rel Volume0.79 Prev Close33.36
Employees18456 LT Debt/Eq0.60 EarningsMar 02 BMO SMA200-2.29% Avg Volume878.76K Price33.04
IPONov 16, 1999 Option/ShortYes / Yes EPS/Sales Surpr.2.05% 15.48% Trades Volume692,405 Change-0.96%
Date Action Analyst Rating Change Price Target Change
Dec-15-25Downgrade RBC Capital Mkts Outperform → Sector Perform
Oct-14-25Downgrade Bernstein Outperform → Mkt Perform $37.50
Apr-25-25Downgrade HSBC Securities Buy → Hold
Mar-12-25Downgrade UBS Buy → Neutral
Nov-06-24Downgrade Berenberg Buy → Hold
Nov-01-24Downgrade Deutsche Bank Buy → Hold
Jul-24-24Initiated Deutsche Bank Buy
Jun-05-24Upgrade UBS Neutral → Buy
Nov-28-23Upgrade Barclays Underweight → Equal Weight
Nov-03-23Upgrade JP Morgan Neutral → Overweight
Mar-10-26 10:30AM
Mar-03-26 08:04PM
01:00PM
11:32AM
Mar-02-26 01:00PM
06:26AM Loading…
06:26AM
05:15AM
02:57AM
Feb-25-26 10:35AM
Feb-24-26 10:28AM
Feb-23-26 04:30PM
09:40AM
Feb-10-26 08:12PM
Jan-22-26 03:10AM
Jan-21-26 12:15PM
12:34PM Loading…
Jan-19-26 12:34PM
Jan-16-26 08:28PM
Jan-14-26 01:19AM
Dec-01-25 05:00AM
Nov-17-25 11:37AM
Nov-06-25 08:33PM
Oct-29-25 09:27PM
Oct-27-25 11:30AM
Oct-22-25 11:30AM
Oct-20-25 06:31AM
Oct-09-25 12:30PM
Oct-08-25 11:40AM
Oct-03-25 11:53AM
Oct-01-25 01:00PM
Sep-25-25 09:40AM
11:40AM Loading…
Sep-22-25 11:40AM
Sep-15-25 12:00PM
Sep-11-25 08:00AM
Sep-03-25 10:16AM
Sep-02-25 04:26PM
11:40AM
Aug-22-25 05:10AM
Aug-15-25 11:40AM
Aug-06-25 12:38PM
Aug-05-25 07:52PM
Jul-28-25 11:40AM
09:40AM
Jul-26-25 12:19AM
Jul-11-25 11:40AM
09:40AM
Jul-07-25 10:00AM
Jun-29-25 07:00AM
Jun-26-25 10:55AM
Jun-25-25 11:40AM
09:40AM
Jun-24-25 10:00AM
Jun-23-25 08:00AM
Jun-20-25 11:40AM
Jun-18-25 04:00AM
Jun-09-25 10:00AM
May-27-25 10:00AM
May-14-25 08:00AM
May-07-25 08:00AM
May-05-25 02:00AM
May-02-25 05:42PM
Apr-30-25 11:58PM
Apr-29-25 04:30PM
09:40AM
06:24AM
Apr-19-25 10:09PM
Apr-08-25 07:38PM
Apr-01-25 10:02AM
Mar-11-25 11:00AM
Mar-10-25 11:00AM
Mar-06-25 10:00AM
Mar-05-25 11:21AM
Mar-04-25 09:00AM
Feb-26-25 02:01AM
Feb-25-25 09:01PM
Feb-16-25 06:00PM
Feb-11-25 10:53PM
Feb-03-25 10:00AM
Jan-14-25 08:00AM
Dec-30-24 06:04AM
Dec-29-24 04:20AM
Dec-19-24 10:00AM
Dec-16-24 10:00AM
Dec-06-24 11:18AM
Oct-31-24 03:49PM
12:27PM
Oct-16-24 09:00AM
Oct-14-24 09:26AM
Oct-09-24 08:00AM
Oct-02-24 08:00AM
Sep-25-24 04:54PM
Sep-18-24 10:00AM
Sep-12-24 10:57AM
Sep-11-24 08:30AM
Sep-10-24 10:00AM
Aug-12-24 11:21AM
Aug-07-24 01:10PM
Aug-01-24 04:05PM
Jul-30-24 08:00AM
Jul-24-24 09:40AM
Jul-17-24 12:27PM
Smith & Nephew plc engages in the development, manufacture, marketing, and sale of medical devices. It operates through the following segments: Orthopaedics, Sports Medicine and ENT, and Advanced Wound Management. The Orthopaedics and Sports Medicine and ENT segment consists of the following businesses: knee implants, hip implants, other reconstruction, trauma, sports medicine joint repair, arthroscopic enabling technologies, and ENT. The Advanced Wound Management segment includes advanced wound care, advanced wound bioactives, and advanced wound devices businesses. The company was founded in 1856 and is headquartered in Watford, the United Kingdom.